MAPT and Alzheimer disease: In our pig model here, we make intracerebral injections of either α-synuclein preformed fibrils, postmortem AD human brain homogenate (containing amyloid-β and tau pathology), postmortem DLB human brain homogenate with pure α-synuclein pathology, and control these injections with saline.